deucravacitinib,apremilast
bms,amgen
['psoriasis', 'deucrava', 'deucra', '$bmy']
$bmy u.s. food and drug administration approves sotyktu (deucravacitinib), oral treatment for adults with moderate-to-severe plaque psoriasis 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft